You are here: Home » News-CM » Companies » News
Business Standard

Zydus receives USFDA tentative approval for Esomeprazole Magnesium Delayed-Release Capsules

Capital Market 

has received the tentative approval from the USFDA to market Delayed-Release Capsules (US RLD NEXIUM).

It will be manufactured at the group's formulations manufacturing facility at SEZ,

belongs to the group of medicines termed as reduces the amount of acid secreted by the stomach. The drug is used to treat the symptoms of gastroesophageal reflux disease, to reduce the risk of in some people taking medicines, treat patients with (Helicobacter pylori) along with certain and long-term treatment of conditions where stomach makes too much acid.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, January 21 2019. 15:35 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU